Robert James Sully

Advanz Pharma Services (UK) Ltd. develops pharmaceutical and consumer health products. It is an international specialty pharmaceutical company providing medicines through its four product ranges: Amdipharm, Mercury Pharma, Abcur, and Focus products. The firm owns a broad portfolio of branded and generic pharmaceutical prescription products. The company was founded on February 26, 2003 and is headquartered in London, the United Kingdom.

ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom.

Part of Jones Day LP, the company is a legal services provider based in London, UK. The British company offers a range of legal services to its clients.